Core Viewpoint - Hengfeng Paper's stock price has experienced fluctuations, with a year-to-date increase of 22.77% but a recent decline in the last five and twenty trading days [1][2]. Company Overview - Hengfeng Paper, established on March 6, 1994, and listed on April 19, 2001, is located in Mudanjiang, Heilongjiang Province. The company specializes in the production and sale of specialty papers, including cigarette paper, filter rod paper, and aluminum foil lining paper [1]. - The revenue composition of Hengfeng Paper includes 65.48% from tobacco industrial paper, 15.50% from other paper types, 11.75% from mechanical gloss paper, 6.08% from thin printing paper, and 1.19% from other sources [1]. Financial Performance - As of September 30, 2025, Hengfeng Paper reported a revenue of 2.039 billion yuan, reflecting a year-on-year growth of 6.29%. The net profit attributable to shareholders was 148 million yuan, marking a significant increase of 34.76% compared to the previous year [2]. - The company has distributed a total of 680 million yuan in dividends since its A-share listing, with 115 million yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Hengfeng Paper was 14,600, a decrease of 12.06% from the previous period. The average circulating shares per person increased by 13.71% to 20,445 shares [2]. - Notable new institutional shareholders include the Jiangyin State-owned Enterprise Reform Flexible Allocation Mixed A Fund, which holds 5.6999 million shares, and the招商量化精选股票发起式A Fund, holding 4.3094 million shares [3].

11月17日，通化金马盘中上涨2.23%，截至11:05，报29.39元/股，成交3.93亿元，换手率1.41%，总市值 284.05亿元。 资金流向方面，主力资金净流出1759.63万元，特大单买入2862.41万元，占比7.28%，卖出4253.98万 元，占比10.82%；大单买入1.15亿元，占比29.36%，卖出1.19亿元，占比30.29%。 通化金马所属申万行业为：医药生物-化学制药-化学制剂。所属概念板块包括：民营医院、工业大麻、 东北振兴、肝炎治疗、中药等。 截至9月30日，通化金马股东户数3.82万，较上期减少3.20%；人均流通股25266股，较上期增加3.31%。 2025年1月-9月，通化金马实现营业收入8.92亿元，同比减少7.88%；归母净利润2496.35万元，同比增长 4.35%。 分红方面，通化金马A股上市后累计派现2.10亿元。近三年，累计派现0.00元。 机构持仓方面，截止2025年9月30日，通化金马十大流通股东中，创新药（159992）位居第七大流通股 东，持股919.30万股，相比上期增加8.78万股。南方中证1000ETF（512100）位居第八大流通股东，持 ...

Core Viewpoint - The stock of Shouxiangu has shown a slight increase in recent trading sessions, with a notable rise in trading volume and a positive net inflow of funds, indicating investor interest despite a decline in revenue and profit year-on-year [1][2]. Company Overview - Shouxiangu Pharmaceutical Co., Ltd. is located in Wuyi County, Zhejiang Province, and was established on March 3, 1997. It was listed on May 10, 2017. The company specializes in the breeding, cultivation, processing, and sales of valuable traditional Chinese medicinal materials such as Ganoderma and Dendrobium [2]. - The main business revenue composition includes: Ganoderma spore powder products (71.92%), Dendrobium products (15.57%), other products (10.88%), and supplementary products (1.63%) [2]. Stock Performance - As of November 14, the stock price of Shouxiangu increased by 2.16%, reaching 21.30 CNY per share, with a trading volume of 33.55 million CNY and a turnover rate of 0.80%. The total market capitalization is 4.22 billion CNY [1]. - Year-to-date, the stock price has risen by 1.72%, with a 3.60% increase over the last five trading days, a 3.40% increase over the last 20 days, and a 3.75% decrease over the last 60 days [2]. Financial Performance - For the period from January to September 2025, Shouxiangu reported a revenue of 430 million CNY, a year-on-year decrease of 8.88%. The net profit attributable to the parent company was 76.34 million CNY, down 35.67% year-on-year [2]. - Since its A-share listing, Shouxiangu has distributed a total of 436 million CNY in dividends, with 218 million CNY distributed in the last three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Shouxiangu was 22,700, a decrease of 4.31% from the previous period. The average circulating shares per person increased by 4.51% to 8,727 shares [2]. - Among the top ten circulating shareholders, the Rongtong Health Industry Flexible Allocation Mixed A/B fund holds 1.2823 million shares, an increase of 82,300 shares compared to the previous period [3].

吉峰科技今年以来股价涨65.55%，近5个交易日涨3.37%，近20日涨1.48%，近60日涨3.86%。 资料显示，吉峰三农科技服务股份有限公司位于四川省成都市郫县成都现代工业港北部园区港通北二路 219号，成立日期1994年12月8日，上市日期2009年10月30日，公司主营业务涉及农业机械、载货汽车、 工程机械产品等现代农业装备的销售与服务。主营业务收入构成为：农机流通板块90.33%，农机制造 板块9.67%。 11月14日，吉峰科技盘中下跌2.09%，截至09:48，报8.89元/股，成交4046.76万元，换手率0.91%，总市 值43.94亿元。 资金流向方面，主力资金净流出222.69万元，特大单买入384.58万元，占比9.50%，卖出190.26万元，占 比4.70%；大单买入697.71万元，占比17.24%，卖出1114.73万元，占比27.55%。 截至9月30日，吉峰科技股东户数2.13万，较上期增加9.68%；人均流通股23206股，较上期减少8.83%。 2025年1月-9月，吉峰科技实现营业收入22.24亿元，同比增长3.47%；归母净利润-731.50万元，同比增 长69. ...

三力士今年以来股价涨10.49%，近5个交易日涨4.41%，近20日涨8.72%，近60日涨1.07%。 截至9月30日，三力士股东户数5.12万，较上期增加0.02%；人均流通股15742股，较上期减少0.02%。 2025年1月-9月，三力士实现营业收入7.14亿元，同比增长21.75%；归母净利润2765.11万元，同比减少 45.76%。 11月13日，三力士盘中上涨2.16%，截至10:36，报4.74元/股，成交7247.53万元，换手率1.92%，总市值 42.76亿元。 分红方面，三力士A股上市后累计派现4.63亿元。近三年，累计派现8972.71万元。 资金流向方面，主力资金净流入822.64万元，特大单买入608.39万元，占比8.39%，卖出280.80万元，占 比3.87%；大单买入1885.60万元，占比26.02%，卖出1390.55万元，占比19.19%。 资料显示，三力士股份有限公司位于浙江省绍兴市柯桥区柯岩街道凤凰创新园，成立日期2002年11月11 日，上市日期2008年4月25日，公司主营业务涉及生产并销售各类橡胶V带、同步带等产品。主营业务 收入构成为：橡胶V带72.7 ...

Company Overview - Qizhou Dongfeng New Materials Group Co., Ltd. is located in Shantou, Guangdong Province, and was established on December 30, 1983. The company was listed on February 16, 2012. Its main business involves the design, production, and sales of cigarette labels and related packaging materials [1][2]. Financial Performance - For the period from January to September 2025, Qizhou Dongfeng achieved operating revenue of 916 million yuan, a year-on-year decrease of 12.54%. The net profit attributable to the parent company was -95.4971 million yuan, representing a year-on-year increase of 49.83% [2]. - The company has cumulatively distributed 4.134 billion yuan in dividends since its A-share listing, with a total of 46.0741 million yuan distributed over the past three years [3]. Stock Performance - As of November 13, Qizhou Dongfeng's stock price increased by 2.05%, reaching 4.97 yuan per share, with a total market capitalization of 9.262 billion yuan. The stock has risen by 24.87% year-to-date, with a recent decline of 0.40% over the last five trading days [1]. - The company has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on January 24 [1]. Shareholder Information - As of September 30, 2025, the number of shareholders for Qizhou Dongfeng was 31,500, a decrease of 11.45% from the previous period. The average circulating shares per person increased by 12.28% to 59,077 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 11.9868 million shares, a decrease of 932,700 shares compared to the previous period [3]. Industry Classification - Qizhou Dongfeng is classified under the light industry manufacturing sector, specifically in packaging and printing, with a focus on paper packaging. The company is associated with concepts such as low price, state-owned enterprise reform, small-cap stocks, industrial hemp, and margin financing [2].

Core Viewpoint - Yunnan Chengtou's stock price has shown a slight increase this year, but recent trading data indicates a net outflow of funds, suggesting potential investor concerns about the company's performance and market position [1][2]. Financial Performance - For the period from January to September 2025, Yunnan Chengtou reported operating revenue of 1.336 billion yuan, a year-on-year decrease of 2.97% [2]. - The company recorded a net profit attributable to shareholders of -35.22 million yuan, representing a significant year-on-year decline of 296.01% [2]. Stock Market Activity - As of November 12, Yunnan Chengtou's stock price was 2.72 yuan per share, with a market capitalization of 4.367 billion yuan [1]. - The stock has increased by 1.87% year-to-date, with a 0.74% rise over the last five trading days, a 5.02% increase over the last 20 days, and a 9.68% increase over the last 60 days [1]. Shareholder Information - As of October 31, the number of shareholders for Yunnan Chengtou was 54,200, an increase of 3.25% from the previous period [2]. - The average number of circulating shares per shareholder was 29,629, a decrease of 3.15% from the previous period [2]. Dividend History - Since its A-share listing, Yunnan Chengtou has distributed a total of 707 million yuan in dividends, with no dividends paid in the last three years [3]. Institutional Holdings - As of September 30, 2025, the sixth largest circulating shareholder was the Southern CSI Real Estate ETF, holding 12.1863 million shares, which is a decrease of 82,200 shares from the previous period [3].

Core Points - The stock price of Shunhao Co., Ltd. decreased by 2.18% on November 12, trading at 7.17 yuan per share with a market capitalization of 7.6 billion yuan [1] - The company has seen a year-to-date stock price increase of 138.92%, but has experienced a decline of 5.03% over the last five trading days [1] - Shunhao Co. reported a revenue of 899 million yuan for the first nine months of 2025, a year-on-year decrease of 20.57%, while net profit attributable to shareholders increased by 20.29% to 67.32 million yuan [2] Company Overview - Shunhao Co. was established on December 21, 2004, and went public on March 18, 2011. The company is located in Putuo District, Shanghai [1] - The main business activities include the research, production, processing, and sales of vacuum aluminum-coated paper, composite film paper, white cardboard, printed products, and tobacco polypropylene fiber bundles [1] - The revenue composition of the company includes printed products (48.07%), aluminum-coated paper (30.03%), and other categories [1] Shareholder Information - As of September 30, the number of shareholders for Shunhao Co. was 43,900, a decrease of 4.61% from the previous period [2] - The average number of circulating shares per shareholder increased by 4.83% to 24,123 shares [2] Dividend Information - Since its A-share listing, Shunhao Co. has distributed a total of 427 million yuan in dividends, with 68.81 million yuan distributed over the past three years [3]

Core Viewpoint - Tonghua Jinma's stock price has shown significant growth this year, with a year-to-date increase of 76.75%, despite a slight decline in the last five trading days [1][2]. Financial Performance - For the period from January to September 2025, Tonghua Jinma reported operating revenue of 892 million yuan, a year-on-year decrease of 7.88%, while the net profit attributable to shareholders increased by 4.35% to 24.96 million yuan [2]. - The company has cumulatively distributed 210 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Stock Market Activity - As of November 11, 2023, Tonghua Jinma's stock was trading at 27.75 yuan per share, with a market capitalization of 26.82 billion yuan [1]. - The stock has appeared on the "Dragon and Tiger List" twice this year, with the most recent net purchase of 142 million yuan on September 11 [1]. Shareholder Structure - As of September 30, 2025, the number of shareholders was 38,200, a decrease of 3.20% from the previous period, with an average of 25,266 circulating shares per shareholder, an increase of 3.31% [2][3]. - Notable shareholders include Innovation Drug and Southern CSI 1000 ETF, with changes in their holdings compared to the previous period [3].

Core Viewpoint - Dezheng Health's stock price has experienced fluctuations, with a year-to-date increase of 39.30%, but a recent decline in trading performance [1][2]. Group 1: Stock Performance - On November 11, Dezheng Health's stock fell by 2.02%, trading at 4.36 CNY per share, with a total market capitalization of 9.143 billion CNY [1]. - The stock has seen a net outflow of 21.3992 million CNY in principal funds, with significant selling pressure observed [1]. - Year-to-date, the stock has risen by 39.30%, but has seen a slight decline of 1.13% over the last five trading days [1]. Group 2: Financial Performance - For the period from January to September 2025, Dezheng Health reported a revenue of 278 million CNY, a year-on-year decrease of 21.71%, and a net profit attributable to shareholders of -61.0254 million CNY, a significant decline of 854.37% [2]. - The company has not distributed any dividends in the last three years, with a total payout of 470 million CNY since its A-share listing [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders decreased to 57,600, with an average of 36,404 circulating shares per person, reflecting a slight decline [2]. - The Hong Kong Central Clearing Limited has exited the list of the top ten circulating shareholders [3].